TP53 mutational status and cetuximab benefit in rectal cancer: 5-year results of the EXPERT-C trial.

F. Sclafani, D. Gonzalez, D. Cunningham, S. Hulkki Wilson, C. Peckitt, J. Tabernero, B. Glimelius, A. Cervantes, A. Dewdney, Andrew Wotherspoon, Gina Brown, D. Tait, J. Oates, I. Chau

Research output: Contribution to journalArticlepeer-review

37 Citations (Scopus)

Search results